275 related articles for article (PubMed ID: 31985052)
1. Retrospective Chart Review of Intravenous Valproate Sodium as a Preventive Treatment for Patients With Chronic Migraine.
Riggins N; Ehrlich A; Sawhney H; Dapkus L; Levin M
Headache; 2020 Mar; 60(3):617-620. PubMed ID: 31985052
[TBL] [Abstract][Full Text] [Related]
2. Low-dose sodium valproate versus low-dose propranolol in prophylaxis of common migraine headache: A randomized, prospective, parallel, open-label study.
Dakhale GN; Sharma VS; Thakre MN; Kalikar M
Indian J Pharmacol; 2019; 51(4):255-262. PubMed ID: 31571712
[TBL] [Abstract][Full Text] [Related]
3. Comparison of intravenous valproate versus intramuscular dihydroergotamine and metoclopramide for acute treatment of migraine headache.
Edwards KR; Norton J; Behnke M
Headache; 2001; 41(10):976-80. PubMed ID: 11903525
[TBL] [Abstract][Full Text] [Related]
4. Implementation of an Intravenous Dihydroergotamine Protocol for Refractory Migraine in Children.
Theroux LM; Cappa R; Mendoza A; Mallawaarachchi I; Samanta D; Goodkin HP
Headache; 2020 Sep; 60(8):1653-1663. PubMed ID: 32853454
[TBL] [Abstract][Full Text] [Related]
5. A randomized trial of propranolol versus sodium valproate for the prophylaxis of migraine in pediatric patients.
Bidabadi E; Mashouf M
Paediatr Drugs; 2010 Aug; 12(4):269-75. PubMed ID: 20593910
[TBL] [Abstract][Full Text] [Related]
6. Intravenous valproate sodium in the treatment of daily headache.
Schwartz TH; Karpitskiy VV; Sohn RS
Headache; 2002 Jun; 42(6):519-22. PubMed ID: 12167141
[TBL] [Abstract][Full Text] [Related]
7. The efficacy of magnesium oxide and sodium valproate in prevention of migraine headache: a randomized, controlled, double-blind, crossover study.
Karimi N; Razian A; Heidari M
Acta Neurol Belg; 2021 Feb; 121(1):167-173. PubMed ID: 30798472
[TBL] [Abstract][Full Text] [Related]
8. Safety and efficacy of intravenous sodium valproate in the treatment of acute migraine.
Waberzinek G; Marková J; Mastík J
Neuro Endocrinol Lett; 2007 Feb; 28(1):59-64. PubMed ID: 17277725
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and Safety of Repetitive Intravenous Sodium Valproate in Pediatric Patients With Refractory Chronic Headache Disorders: A Retrospective Review.
Pavitt S; Gelfand AA; Zorrilla N; Allen I; Riggins N
Pediatr Neurol; 2022 Mar; 128():52-57. PubMed ID: 35093793
[TBL] [Abstract][Full Text] [Related]
10. Levetiracetam in Compare to Sodium Valproate for Prophylaxis in Chronic Migraine Headache: A Randomized Double-Blind Clinical Trial.
Kashipazha D; Ghadikolaei HS; Siavashi M
Curr Clin Pharmacol; 2017; 12(1):55-59. PubMed ID: 28356053
[TBL] [Abstract][Full Text] [Related]
11. Understanding the migraine treatment landscape prior to the introduction of calcitonin gene-related peptide inhibitors: Results from the Assessment of TolerabiliTy and Effectiveness in MigrAINe Patients using Preventive Treatment (ATTAIN) study.
Kawata AK; Shah N; Poon JL; Shaffer S; Sapra S; Wilcox TK; Shah S; Tepper SJ; Dodick DW; Lipton RB
Headache; 2021 Mar; 61(3):438-454. PubMed ID: 33594686
[TBL] [Abstract][Full Text] [Related]
12. Effect of intravenous sodium valproate vs dexamethasone on acute migraine headache: a double blind randomized clinical trial.
Mazaheri S; Poorolajal J; Hosseinzadeh A; Fazlian MM
PLoS One; 2015; 10(3):e0120229. PubMed ID: 25793707
[TBL] [Abstract][Full Text] [Related]
13. A comparative study of the effects of low-dose topiramate versus sodium valproate in migraine prophylaxis.
Afshari D; Rafizadeh S; Rezaei M
Int J Neurosci; 2012 Feb; 122(2):60-8. PubMed ID: 21950578
[TBL] [Abstract][Full Text] [Related]
14. Treatment of chronic migraine: a 3-month comparator study of naproxen sodium vs SumaRT/Nap.
Cady R; Nett R; Dexter K; Freitag F; Beach ME; Manley HR
Headache; 2014 Jan; 54(1):80-93. PubMed ID: 24020994
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and mechanism of anticonvulsant drugs in migraine.
Hoffmann J; Akerman S; Goadsby PJ
Expert Rev Clin Pharmacol; 2014 Mar; 7(2):191-201. PubMed ID: 24494792
[TBL] [Abstract][Full Text] [Related]
16. Treatment of primary headache disorders with intravenous valproate: initial outpatient experience.
Stillman MJ; Zajac D; Rybicki LA
Headache; 2004 Jan; 44(1):65-9. PubMed ID: 14979885
[TBL] [Abstract][Full Text] [Related]
17. Visual cortex excitability in migraine before and after valproate prophylaxis: a pilot study using TMS.
Mulleners WM; Chronicle EP; Vredeveld JW; Koehler PJ
Eur J Neurol; 2002 Jan; 9(1):35-40. PubMed ID: 11784374
[TBL] [Abstract][Full Text] [Related]
18. The effects of cinnarizine versus sodium valproate in migraine prophylaxis.
Bostani A; Rajabi A; Moradian N; Razazian N; Rezaei M
Int J Neurosci; 2013 Jul; 123(7):487-93. PubMed ID: 23311688
[TBL] [Abstract][Full Text] [Related]
19. Intravenous Valproate versus Subcutaneous Sumatriptan in Acute Migraine Attack.
Ghaderibarmi F; Tavakkoli N; Togha M
Acta Med Iran; 2015 Oct; 53(10):633-6. PubMed ID: 26615376
[TBL] [Abstract][Full Text] [Related]
20. Divalproex in the treatment of migraine.
Freitag FG
Psychopharmacol Bull; 2003; 37 Suppl 2():98-115. PubMed ID: 15021865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
